HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weidong Wang Selected Research

Fanconi Anemia Complementation Group Proteins

2/2004FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination.
10/2003A novel ubiquitin ligase is deficient in Fanconi anemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Weidong Wang Research Topics

Disease

37Neoplasms (Cancer)
06/2022 - 02/2003
22Inflammation (Inflammations)
04/2022 - 12/2012
17Fanconi Anemia (Fanconi's Anemia)
01/2019 - 05/2003
14Polyuria
01/2022 - 01/2002
11Ureteral Obstruction
01/2019 - 05/2003
10Genomic Instability
01/2022 - 03/2006
9Lung Neoplasms (Lung Cancer)
04/2022 - 02/2003
8Breast Neoplasms (Breast Cancer)
01/2021 - 10/2003
8Acute Kidney Injury (Acute Renal Failure)
01/2021 - 12/2003
8Hypersensitivity (Allergy)
09/2012 - 11/2004
7Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2018
7COVID-19
01/2022 - 01/2020
7Nephrogenic Diabetes Insipidus
01/2019 - 04/2004
6Insulin Resistance
01/2022 - 01/2019
6Kidney Diseases (Kidney Disease)
01/2022 - 01/2016
6Body Weight (Weight, Body)
12/2021 - 10/2005
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 09/2015
6Bloom Syndrome
01/2016 - 04/2005
5Obesity
01/2022 - 01/2017
5Wounds and Injuries (Trauma)
01/2022 - 08/2004
5Fibrosis (Cirrhosis)
01/2022 - 07/2013
5Hypoxia (Hypoxemia)
01/2021 - 07/2008
5Dehydration (Water Stress)
02/2019 - 02/2014
4Neoplasm Metastasis (Metastasis)
06/2022 - 09/2013
4Carcinogenesis
04/2022 - 05/2019
4Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 01/2017
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2020
4Type 2 Diabetes Mellitus (MODY)
12/2021 - 05/2015
4Hypercalcemia (Milk Alkali Syndrome)
01/2021 - 01/2002
4Hypertension (High Blood Pressure)
09/2020 - 11/2005
4Chromosomal Instability (Chromosome Stability)
08/2009 - 10/2004
3Hyperglycemia
01/2022 - 06/2006
3Pneumonia (Pneumonitis)
01/2022 - 01/2020
3Stomach Neoplasms (Stomach Cancer)
01/2022 - 11/2017
3Adenocarcinoma of Lung
01/2022 - 02/2003
3Dysbiosis
01/2022 - 07/2020
3Premature Birth (Birth, Premature)
01/2022 - 02/2020
3Proteinuria
01/2022 - 05/2004
3Esophageal Squamous Cell Carcinoma
02/2021 - 01/2018
3Hemorrhage
02/2021 - 06/2012
3Ischemia
01/2021 - 08/2004
3Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 01/2015
3Portal Hypertension
12/2020 - 04/2019
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2016 - 02/2014
3Ataxia Telangiectasia (Louis Bar Syndrome)
08/2009 - 09/2006
2Ischemic Stroke
05/2022 - 12/2019
2Diabetes Mellitus
01/2022 - 01/2019
2Stroke (Strokes)
01/2022 - 12/2019

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2003
21DNA (Deoxyribonucleic Acid)IBA
06/2020 - 09/2003
14Particulate MatterIBA
03/2022 - 10/2019
12Aquaporins (Water Channels)IBA
01/2021 - 12/2002
10Biomarkers (Surrogate Marker)IBA
04/2022 - 04/2015
8Aquaporin 2IBA
01/2021 - 05/2003
8SodiumIBA
06/2008 - 11/2003
7LipidsIBA
01/2022 - 01/2011
7CytokinesIBA
01/2022 - 01/2011
7LithiumIBA
01/2019 - 04/2004
6Messenger RNA (mRNA)IBA
07/2022 - 04/2005
6Biological ProductsIBA
04/2022 - 08/2012
6CholesterolIBA
01/2022 - 12/2012
6Insulin (Novolin)FDA Link
01/2022 - 02/2013
6Pharmaceutical PreparationsIBA
08/2021 - 01/2018
5MicroRNAs (MicroRNA)IBA
03/2022 - 04/2015
5EnzymesIBA
01/2022 - 04/2004
5Long Noncoding RNAIBA
01/2022 - 01/2018
4Blood Glucose (Blood Sugar)IBA
03/2022 - 12/2019
4OzoneIBA
01/2022 - 01/2022
4LigandsIBA
01/2022 - 12/2012
4RNA (Ribonucleic Acid)IBA
01/2022 - 09/2013
4CreatinineIBA
01/2021 - 12/2003
4aliskirenFDA Link
01/2019 - 12/2014
4Renin InhibitorsIBA
01/2019 - 12/2014
4A-Form DNA (A-DNA)IBA
02/2007 - 10/2003
3ElementsIBA
05/2022 - 02/2014
3CalciumIBA
01/2022 - 03/2004
3Hormones (Hormone)IBA
01/2022 - 02/2006
3Glucose (Dextrose)FDA LinkGeneric
12/2021 - 01/2018
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2021 - 01/2016
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
12/2021 - 12/2012
3Transcription Factors (Transcription Factor)IBA
01/2021 - 02/2014
3Ligases (Synthetase)IBA
01/2021 - 10/2003
3Therapeutic UsesIBA
01/2021 - 01/2019
3Drinking WaterIBA
07/2020 - 06/2006
3InflammasomesIBA
01/2019 - 04/2015
3Hemoglobins (Hemoglobin)IBA
01/2019 - 01/2015
3Small Interfering RNA (siRNA)IBA
01/2018 - 02/2007
3AntibodiesIBA
08/2016 - 09/2003
3Carrier Proteins (Binding Protein)IBA
04/2015 - 08/2005
3Mitomycin (Mitomycin-C)FDA LinkGeneric
05/2014 - 10/2003
3UbiquitinIBA
07/2012 - 10/2003
3Adenosine Triphosphatases (ATPase)IBA
02/2006 - 02/2003
2Photosensitizing Agents (Photosensitizers)IBA
01/2022 - 01/2021
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 01/2020
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2018

Therapy/Procedure

21Therapeutics
06/2022 - 12/2004
7Radiotherapy
06/2022 - 08/2012
3Lymph Node Excision (Lymph Node Dissection)
01/2022 - 01/2019
2Phototherapy (Light Therapy)
01/2022 - 01/2021
2Drug Therapy (Chemotherapy)
01/2022 - 09/2013